Category Archives: Mike Yeadon

Gold Update … Watch The Tape

November 4, 2022 By in Biotech, GLD, LABD, LABD-22-09, Mike Yeadon, Positions, SPBIO 2 Comments

Potential Danger, For The Upside

It’s still in the early session and gold GLD, is trading higher … for now.

This morning, once GLD started to post on the tape, a new potential up-thrust (reversal) target became apparent.

The reason to think GLD, upside may be short-lived, just after the open, biotech began declining in earnest … signaling potential overall weakness for the rest of the market(s).

No one wants to talk about this sector and what’s really going on.

We don’t know when it’s all going to let loose but the pressures are immense and they continue to build.

Back to gold.

The daily chart of GLD, is below with the area in question, highlighted.

Gold GLD, Daily

Price action must get above and stay above the resistance area. Otherwise, it’s an up-thrust (reversal).

Other Markets & Biotech

Meanwhile, the biotech sector (SPBIO), is the first to post new daily lows. At this juncture, all other major indicies are higher.

Once again, as shown below, the short position via LABD, has been increased (not advice, not a recommendation).

Positions, Market Stance (courtesy only, not advice).

LABD-22-09:

Special Note:

This sector and leveraged inverse LABD are highly volatile. Character of the market can change at any time. LABD may be exited without notice.

Entry @ 19.88, 19.71, 21.23, 21.65*** Stop @ 19.41***

Note: Positions may be increased, decreased, entered, or exited at any time.

***, Indicates change

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech: Now, It Gets Real

July 5, 2021 By in Biotech, BIS, IBB, LABD, Mike Yeadon, The Speck, Vernon Coleman, Wyckoff 1 Comment

Biotech reversal

No one is looking

The only way for price action to even hope of printing a Fibonacci series (daily chart), is when virtually no one is looking.

A quick YouTube search of “Biotech analysis“, turns up these links:

Best Biotech Growth Stock to Buy Now?? : Vertex Pharmaceuticals (VRTX) Stock Analysis

3 Cheap Biotech Stocks With 100% Upside in 2021

Biotech analyst on CRISPR technology: Early data is very promising

Those three, are the most recent.

Looking at each, none of them even hint things could go wrong.

To be really cynical (and probably correct), the senior trading professionals may know this sector’s at risk of implosion.

They task junior employees to cover it; attempting to talk it up.

Analysis: SPBIO

Moving on to inverse fund LABD, we have Fibonacci correlation on two time frames:

In addition, from a Wyckoff standpoint, we’re in spring position on the weekly and daily time frames.

All of this points to high probability (not advice, not a recommendation) that biotech and specifically the weaker SPBIO, has pivoted to the downside (LABD higher).

Naming Names:

A couple of days ago, we had Dr. Yeadon (former Chief Scientist, Pfizer) absolutely grilling and eviscerating his interviewers, covered here.

Then, we have Dr. Coleman deciding to name, names.

Now, it’s getting real.

With this type of high-level pressure being applied from internationally known and respected (real) heroes, one has to think, it can’t be long before the lie is fully exposed; blowing the entire sector, wide open.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.